proline has been researched along with arginine vasopressin in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (62.50) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walter, R | 1 |
| Atkinson, AB; Brown, JJ; Davies, DL; Fraser, R; Leckie, B; Lever, AF; Morton, JJ; Robertson, JI | 1 |
| Larsson, LE; Melin, P; Ragnarsson, U | 1 |
| Hasser, EM; Haywood, JR; Segura, T; Shade, RE | 1 |
| Brennan, TJ; Haywood, JR; Hinojosa, C | 1 |
| Cazalis, M; Nordmann, JJ | 1 |
| Casey, DJ; Johnston, CI; Millar, JA | 1 |
| Holzschuh, M; Kochsiek, K; Liebau, G; Riegger, GA; Steilner, H; Witkowski, D | 1 |
| Bie, P; Warberg, J | 1 |
| Benlamlih, S; Dahlborn, K; Fyhrquist, F; Olsson, K | 1 |
| Browning, JE; Repaske, DR | 1 |
| Hensen, J; Lehnert, H; Mundschenk, J; Rittig, S; Siggaard, C | 1 |
| Acharjee, S; Ahn, RS; Choe, H; Do-Rego, JL; Kim, K; Kwon, HB; Oh, da Y; Oh, DY; Seong, JY; Vaudry, H | 1 |
| Lammek, B; Prahl, A; Slaninová, J; Sobolewski, D | 1 |
| Feng, M; Jing, H; Li, J; Liu, C; Liu, K; Qin, J; Wang, C; Wang, F; Wang, T; Zhu, J | 1 |
| Borovičková, L; Kwiatkowska, A; Lammek, B; Lewandowska, M; Prahl, A; Slaninová, J | 1 |
1 review(s) available for proline and arginine vasopressin
| Article | Year |
|---|---|
Neurohumoral mechanisms of sodium-dependent hypertension.
Topics: Animals; Arginine Vasopressin; Diet, Sodium-Restricted; gamma-Aminobutyric Acid; Humans; Hypertension; Hypertension, Renal; Neurotransmitter Agents; Nipecotic Acids; Proline; Saline Solution, Hypertonic; Sodium | 1985 |
15 other study(ies) available for proline and arginine vasopressin
| Article | Year |
|---|---|
Partial purification and characterization of post-proline cleaving enzyme: enzymatic inactivation of neurohypophyseal hormones by kidney preparations of various species.
Topics: Animals; Arginine Vasopressin; Cations, Divalent; Cats; Cricetinae; Dithiothreitol; Dogs; Edetic Acid; Female; Humans; Hydrogen-Ion Concentration; Kidney; Kinetics; Lypressin; Mice; Organ Specificity; Oxytocin; Peptide Hydrolases; Proline; Rabbits; Rats; Sheep; Species Specificity; Swine; Uterus; Vasopressins | 1976 |
Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Arginine Vasopressin; Blood Pressure; Captopril; Female; Humans; Hypertension, Malignant; Hyponatremia; Middle Aged; Potassium; Proline; Renal Artery Obstruction; Renin; Syndrome | 1979 |
Synthesis of peptides by fragment condensation on a solid support. II. A scheme for preparation of 4,8-disubstituted vasopressins evaluated on 8-arginine-vasopressin.
Topics: Arginine Vasopressin; Asparagine; Cysteine; Peptide Fragments; Peptides; Phenylalanine; Proline; Tyrosine; Vasopressins | 1976 |
Evidence of an endogenous forebrain GABAergic system capable of inhibiting baroreceptor-mediated vasopressin release.
Topics: Animals; Arginine Vasopressin; Frontal Lobe; gamma-Aminobutyric Acid; Male; Nipecotic Acids; Pressoreceptors; Proline; Rats; Rats, Inbred Strains; Time Factors | 1989 |
Characterization of newly formed and aged granules in the neurohypophysis.
Topics: Animals; Arginine Vasopressin; Cell Fractionation; Centrifugation, Density Gradient; Cysteine; Cytoplasmic Granules; Isoelectric Focusing; Male; Membrane Proteins; Osmolar Concentration; Pituitary Gland, Posterior; Proline; Rats; Rats, Inbred Strains; Time Factors | 1986 |
Adrenal angiotensin II receptors and vascular reactivity to angiotensin II in the rat during continuous inhibition of angiotensin converting enzyme.
Topics: Adrenal Glands; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Female; Norepinephrine; Proline; Rats; Receptors, Angiotensin; Receptors, Cell Surface | 1980 |
Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine Vasopressin; Captopril; Cardiac Output; Cardiac Pacing, Artificial; Heart Failure; Norepinephrine; Proline; Pulmonary Wedge Pressure; Renin; Renin-Angiotensin System; Vascular Resistance | 1984 |
Effects on intravascular pressures of vasopressin and angiotensin II in dogs.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Diastole; Dogs; Heart Rate; Proline; Systole; Venous Pressure | 1983 |
Effects of captopril on arterial blood pressure, plasma renin activity and vasopressin concentration in sodium-repleted and sodium-deficient goats. A serial study during pregnancy, lactation and anestrus.
Topics: Anestrus; Animals; Arginine Vasopressin; Blood Pressure; Blood Proteins; Captopril; Diet, Sodium-Restricted; Female; Furosemide; Goats; Infusions, Parenteral; Lactation; Potassium; Pregnancy; Proline; Renin; Renin-Angiotensin System; Sodium | 1984 |
A de novo mutation in the coding sequence for neurophysin-II (Pro24-->Leu) is associated with onset and transmission of autosomal dominant neurohypophyseal diabetes insipidus.
Topics: Amino Acid Sequence; Arginine Vasopressin; Base Sequence; Child, Preschool; Chromosomes, Human, Pair 20; Diabetes Insipidus; Exons; Female; Humans; Leucine; Molecular Sequence Data; Mutation; Neurophysins; Pedigree; Pituitary Gland, Posterior; Polymerase Chain Reaction; Proline; Repetitive Sequences, Nucleic Acid | 1994 |
A new mutation of the arginine vasopressin-neurophysin II gene in a family with autosomal dominant neurohypophyseal diabetes insipidus.
Topics: Adult; Arginine; Arginine Vasopressin; Deoxyribonucleases, Type II Site-Specific; Diabetes Insipidus; Exons; Female; Humans; Male; Mutation; Mutation, Missense; Neurophysins; Pedigree; Proline; Sequence Analysis, DNA | 2001 |
Identification of amino acid residues that direct differential ligand selectivity of mammalian and nonmammalian V1a type receptors for arginine vasopressin and vasotocin. Insights into molecular coevolution of V1a type receptors and their ligands.
Topics: Amino Acid Sequence; Amino Acids; Animals; Arginine Vasopressin; Binding Sites; Gene Expression; Genes, fos; Humans; Isoleucine; Models, Molecular; Molecular Sequence Data; Mutagenesis; Phenylalanine; Proline; Promoter Regions, Genetic; Rana catesbeiana; Rats; Receptors, Vasopressin; Recombinant Fusion Proteins; Structure-Activity Relationship; Threonine; Transfection; Tyrosine; Vasotocin | 2004 |
Analogues of arginine vasopressin modified at position 2 with proline derivatives: selective antagonists of oxytocin in vitro.
Topics: Animals; Arginine Vasopressin; In Vitro Techniques; Oxytocin; Proline; Rats | 2009 |
Nitric oxide in enteric nervous system mediated the inhibitory effect of vasopressin on the contraction of circular muscle strips from colon in male rats.
Topics: Animals; Antioxidants; Arginine Vasopressin; Colon; Enteric Nervous System; Female; Humans; I-kappa B Proteins; Male; Muscle Contraction; Muscle, Smooth; Nitric Oxide; Nitric Oxide Synthase Type II; Proline; Rats; Rats, Wistar; Receptors, Vasopressin; Sodium Channel Blockers; Tetrodotoxin; Thiocarbamates; Transcription Factor RelA; Vasoconstrictor Agents | 2011 |
Design, synthesis and structure-activity relationship of new arginine vasopressin analogues containing proline derivatives in position 2.
Topics: Animals; Antidiuretic Agents; Arginine Vasopressin; Drug Design; Humans; Indoles; Kinetics; Proline; Protein Binding; Rats; Rats, Wistar; Receptors, Oxytocin; Structure-Activity Relationship | 2013 |